z-logo
Premium
Captagon: use and trade in the Middle East
Author(s) -
ALImam Ahmed,
Santacroce Rita,
RomanUrrestarazu Andres,
Chilcott Robert,
Bersani Giuseppe,
Martinotti Giovanni,
Corazza Ornella
Publication year - 2017
Publication title -
human psychopharmacology: clinical and experimental
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.461
H-Index - 78
eISSN - 1099-1077
pISSN - 0885-6222
DOI - 10.1002/hup.2548
Subject(s) - middle east , geography , archaeology
Background Fenetheylline, a psychostimulant drug, often branded as Captagon , is a combination of amphetamine and theophylline. Since the cessation of its legal production in 1986, counterfeited products have been produced illicitly in south‐east Europe and far‐east Asia. Its profitable trade has been linked to terrorist organizations, including Islamic State of Iraq and the Levant. This study aims to reach up‐to‐date data, concerning the Captagon e‐commerce and use in the Middle East. Methods A multi‐staged and multi‐lingual literature search was carried out. A list of prespecified keywords was applied across medical and paramedical databases, web and Dark web, search engines, social communication media, electronic commerce websites, media networks, and the Global Public Health Intelligence Network database. Results The use of Captagon as a stimulant in terrorist settings has been marginally covered in the literature. Data can widely be retrieved from Google and AOL search engines, YouTube, and Amazon e‐commerce websites, and to a lesser extent from Alibaba and eBay. On the contrary, Middle Eastern e‐commerce websites yielded almost no results. Interestingly, the Dark web generated original data for Captagon e‐commerce in the Middle East. Conclusion Further investigations are needed on the role that psychoactive drugs play in terrorist attacks and civil war zones. Unless a comprehensive methodological strategy, inclusive of unconventional methods of research, is implemented, it will not be feasible to face such a threat to humanity.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here